The new center serves as a qualitative addition to Al Ain’s healthcare ecosystem, bringing a comprehensive suite of sports medicine subspecialties under one roof 

Al Ain, July 22, 2026: Burjeel Royal Hospital, Asharej, in collaboration with the Abu Dhabi Sports Council, has launched the Burjeel Sports Medicine Center, marking a major step forward in enhancing specialized healthcare services in line with the rapid growth of the Emirate’s sports sector. The opening ceremony was attended by Council representatives, dignitaries, and officials from government entities across Al Ain. The Center delivers an integrated model for injury prevention, diagnosis, treatment, and rehabilitation, with all services adhering to international best practices. 

Designed as a one-stop destination for sports healthcare, the Center brings together multidisciplinary expertise under one roof, spanning orthopedics, physiotherapy, advanced rehabilitation, diagnostic imaging, injury prevention, and athletic performance optimization. This holistic framework ensures a seamless continuum of care, from accurate initial diagnosis to a safe, effective return to play and daily routine. 

The facility caters to a broad spectrum of patients, including elite professional athletes, amateur sports enthusiasts, fitness advocates, pediatric patients, and individuals suffering from musculoskeletal conditions. Powered by a collaborative team of specialists, the Center features cutting-edge medical imaging, such as high-precision MRI, X-ray, and diagnostic ultrasound, alongside state-of-the-art rehabilitation suites and minimally invasive treatment options engineered to accelerate recovery and drive optimal clinical outcomes. 

The opening aligns with Burjeel’s strategic vision to scale sports medicine access across Al Ain, with upcoming expansion plans targeting Burjeel Royal Hospital, Town Center, Burjeel Medical Center, Barari Mall, and Burjeel Day Surgery Center, Al Dhahir. By decentralizing these high-tier services, Burjeel aims to bring specialized care closer to the community while reducing the need for patients to travel elsewhere for treatment. Furthermore, the Center will actively foster partnerships with local sports clubs, educational institutions, and corporate entities to promote injury prevention and athletic wellness across the region. 

Dr. Aysha Al Mahri, CEO, Al Ain Region, Burjeel Holdings said, “The launch of the Burjeel Sports Medicine Center represents a strategic milestone in our ongoing effort to elevate specialized healthcare standards in Al Ain. Developed in response to the surging demand for sports healthcare, this facility fuses elite multidisciplinary expertise with advanced diagnostic and therapeutic technologies. Our goal is to provide end-to-end care, from prevention and intervention to recovery, empowering patients and athletes to return to their active lifestyles with maximum confidence and safety.” 

Dr. Ahmed Al Marzooqi, Medical Director, Burjeel Al Ain, added, “Our Center is engineered to serve as a flagship hub for sports medicine in Al Ain, offering a continuous, patient-centric treatment journey. We focus on delivering personalized care plans designed to speed up recovery, minimize the risk of re-injury, and enhance physical performance. In tandem with modern clinical care, we are deeply committed to community engagement, partnering with local sports clubs, schools, and organizations to drive awareness and nurture a healthier, more active society.” 

The establishment of the Burjeel Sports Medicine Center underscores Burjeel Holdings’ commitment to continuous investment in specialized medical care. By expanding access to advanced, evidence-based therapies, the Group supports the UAE’s broader vision to foster athletic excellence, elevate quality of life in communities, and solidify Al Ain’s position as a growing center for world-class healthcare. 

The collaboration will establish a specialized thoracic surgery program in Abu Dhabi, expanding regional access to advanced, multidisciplinary care for cancers of the lung, esophagus, mediastinum, and chest wall 

New York | Abu Dhabi, July 17, 2026: Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, has entered into a clinical and academic collaboration with New York-based Roswell Park Comprehensive Cancer Center, a US National Cancer Institute-designated Comprehensive Cancer Center, to establish a specialized thoracic surgery program in the UAE. 

The agreement was signed in New York by Dr. Candace S. Johnson, President and CEO of Roswell Park Comprehensive Cancer Center, and Dr. Mujtaba Ali Khan, CEO of Burjeel Medical City. The signing took place in the presence of Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, and Dr. Sai Yendamuri, Senior Vice President, Chief Strategy Officer and Chair of Thoracic Surgery at Roswell Park. 

The collaboration combines Roswell Park’s clinical protocols, multidisciplinary expertise, and academic capabilities with BMC’s advanced infrastructure, oncology services, and network. BMC will establish a dedicated thoracic surgery service for cancers affecting the lungs, esophagus, mediastinum, and chest wall. 

The program will offer robot-assisted, video-assisted thoracoscopic (VATS), and conventional open procedures based on clinical needs. By making specialized thoracic cancer surgery available in Abu Dhabi, the collaborators aim to reduce the need for patients from the UAE and wider MENA region to travel overseas. 

Expanding Access to Specialized Cancer Care 

The program will be integrated into the multidisciplinary care pathway of Burjeel Cancer Institute (BCI), bringing together thoracic surgery, medical oncology, radiation oncology, pulmonology, pathology, and radiology. Patients will receive coordinated care from diagnosis through surgery, recovery, and follow-up. 

Thoracic tumor board meetings will allow BMC physicians to review complex cases with Roswell Park specialists. The collaboration will also provide access to Roswell Park faculty for selected reviews and second opinions. Clinical pathways will align with international standards, including National Comprehensive Cancer Network guidelines. 

Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, said: “This collaboration creates a sustainable pathway for patients in the UAE and across the region to access highly specialized thoracic cancer care closer to home. By combining Roswell Park’s expertise with BMC’s capabilities and regional reach, we aim to strengthen outcomes, build local expertise, and reduce the burden of traveling overseas for complex treatment.” 

Building a Long-Term Academic Relationship 

The lead thoracic surgeon will hold an academic designation with Roswell Park. The institutions will also collaborate on clinical protocol development, scientific programs, educational activities, faculty engagement, clinician exchanges, and professional development. 

Dr. Candace S. Johnson, President and CEO of Roswell Park Comprehensive Cancer Center, said: “Roswell Park has a long-standing commitment to advancing cancer care through collaboration, research, and education.”  

Dr. Sai Yendamuri, Senior Vice President, Chief Strategy Officer and Chair of Thoracic Surgery at Roswell Park Comprehensive Cancer Center, said: “By working with Burjeel Medical City, we can extend specialized thoracic cancer care expertise, support multidisciplinary decision-making, and help build a world-class program serving patients across the UAE and region.” 

Founded in 1898 in Buffalo, New York, Roswell Park was the first institution established exclusively for cancer research and treatment and is a member of the National Comprehensive Cancer Network. 

The program will complement Burjeel Cancer Institute’s multidisciplinary oncology services, including medical oncology, surgical oncology, radiation oncology, advanced imaging, precision diagnostics, and supportive care. 

The patient, treated at Burjeel Hospital, Abu Dhabi, suffered from Adult-Onset Still’s Disease (AOSD), a rare autoimmune condition affecting approximately 1–4 people per million worldwide 

Abu Dhabi: The 34-year-old patient residing in Abu Dhabi had always enjoyed robust health. So, when persistent high-grade fever plagued him for more than two weeks, it was deeply unsettling for him. Despite multiple hospital visits and extensive routine testing, including blood cultures and standard infection screens, the cause of his illness remained unknown, intensifying worries as his condition continued to worsen. With fever, disabling joint pain, extreme fatigue, and evidence of intense inflammation, and liver involvement, his condition started to raise concern as he began to show signs of a potentially life-threatening illness. 

Although he looked stable, the severity and persistence of his symptoms were alarming, prompting the medical team at Burjeel Hospital, Abu Dhabi, to intervene urgently. An in-depth investigation revealed that he was affected by Adult-Onset Still’s Disease (AOSD), a rare autoimmune condition affecting approximately 1–4 people per million worldwide. 

A Difficult-to-Diagnose Disorder  

Dr. Niyas Khalid, Specialist, Internal Medicine, says AOSD is extremely difficult to diagnose because of its rarity and resemblance to other infections. “It mimics many life-threatening diseases such as severe infections, autoimmune disorders, liver disease, and even cancer. It’s often under-recognized, particularly in regions where fever is commonly attributed to infectious causes,” says Dr. Niyas, who treated the patient along with Dr. Abdul Hakeem Muhammed, Specialist, Internal Medicine.  

At the hospital, the patient underwent a series of tests to rule out other possibilities. A major challenge was his body not having rashes, a feature often described in textbooks, but frequently absent or difficult to detect in individuals with darker complexion, adds the doctor.  

In his case, what stood out was the unique combination of prolonged fever, severe inflammation, liver involvement, and extremely high ferritin levels. In addition, all infectious and autoimmune tests had returned negative. “The extraordinarily elevated ferritin, a marker of inflammation, acted as a critical diagnostic signal. When these features came together, along with high-grade fever spiking every day at regular intervals, AOSD became the most plausible explanation, although it is extremely rare,” says Dr. Niyas. 

Fatal if Not Diagnosed in Time 

When affected by AOSD, the patient’s immune system becomes overactive and attacks itself, causing widespread inflammation. If not diagnosed and treated at the right time, the disease can progress to severe complications such as organ damage, chronic inflammatory arthritis, liver failure, or a potentially fatal immune storm known as macrophage activation syndrome. In this case, early intervention was life-altering and, potentially, life-saving. 

“During those days, I shivered from fever and struggled to get up from bed, lift my hands, and move my body. There was no appetite because of throat pain. Despite taking medicine, my fever recurred, draining me emotionally. I prayed to God to give my routine life back,” recalls the patient. 

Rapid Return to Normalcy  

Once AOSD was suspected, the medical team initiated high-dose corticosteroid therapy, the cornerstone treatment for this condition. After the initial high doses, the steroid was tapered carefully over several weeks to suppress the immune reaction while allowing safe recovery. “Within 24 hours, the fever subsided. Within 48 hours, the patient felt significantly better, with improvement in joint pain and energy levels. Laboratory markers improved in parallel,” explains Dr. Niyas. 

“I am so happy that I can move my body without support for the first time after a while. Everyone in the hospital gave me hope whenever I doubted, got frustrated, and questioned myself,” says the patient. 

Although he has recovered remarkably well, ongoing follow-up is essential as AOSD can recur in some patients. He will continue regular follow-up with internal medicine and rheumatology to monitor any signs of relapse and ensure long-term stability. 

Abu Dhabi, UAE, xx June 2026 - Abu Dhabi has marked a global milestone achievement by becoming the first in the world where Camizestrant, a next-generation therapy for advanced breast cancer, has been administered to a patient in a clinical care setting. The treatment is designed to support earlier, more targeted intervention for patients whose cancer has developed resistance to conventional hormone therapy. The achievement reflects Abu Dhabi’s position as a leading destination for best-in-class care, where advanced diagnostics and timely access to specialised treatments are supporting more personalised care. 

Under the supervision of the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, Burjeel Cancer Institute has administered this novel precision therapy to a woman in her forties diagnosed with advanced breast cancer. The patient was found to have an ESR1 gene mutation, which may cause the cancer to become resistant to conventional endocrine treatment and allow the disease to progress. 

The mutation was detected through circulating tumour DNA (ctDNA) monitoring, a blood-based approach that can identify molecular changes linked to treatment resistance before disease progression becomes visible on scans or through clinical symptoms.  

Camizestrant offers a more targeted treatment option for patients whose cancer has developed ESR1 gene mutation. By providing a more precise and personalised treatment option before clear signs of disease progression appear, it may help to control the cancer for longer, delay further progression and preserve patients’ quality of life. 

Commenting on the achievement, H.E Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH) said: The future of healthcare is not defined by treating disease, but by how early we can identify change and intervene before a patient’s condition progresses. Enabling the first global administration of Camizestrant in a clinical setting reflects Abu Dhabi’s vision of building one of the world’s most intelligent and advanced healthcare systems, founded on prevention, early detection, and timely intervention. By accelerating responsible access to advanced therapies with tangible impact at the right time, Abu is enabling precision medicine and more personalised care, improving patient outcomes and reinforcing its position as a leading global destination for healthcare”. 

Prof. Humaid Bin Harmal Al Shamsi, Chief Executive Officer of Burjeel Cancer Institute, added: "We are proud that Burjeel Cancer Institute has become the first centre in the world to treat a patient with this innovative therapy. This milestone reflects Burjeel Cancer Institute’s vision of integrating advanced molecular diagnostics, artificial intelligence, and sophisticated analytical technologies into the patient care pathway, enabling more personalised and precise treatment decisions tailored to the biological characteristics of each individual case." 

He added: "This achievement is not simply about introducing a new drug; it represents the adoption of a comprehensive precision oncology model built on continuous molecular monitoring. Through ctDNA testing, we are now able to detect endocrine therapy resistance at a very early stage and intervene before any radiological or clinical signs of disease progression emerge, giving patients a greater opportunity to control their disease while preserving their quality of life." 

The treatment approach is supported by findings from the global SERENA-6 clinical trial. The study showed that switching patients with an ESR1 mutation detected through ctDNA monitoring to Camizestrant reduced the risk of disease progression or death by 56% compared with continuing conventional endocrine therapy. 

SERENA-6 is the first global registrational trial to use serial ctDNA monitoring to guide a treatment change before radiological or clinical disease progression becomes evident, representing a significant shift in the management of advanced breast cancer. 

Burjeel Cancer Institute continues to strengthen its position as one of the region’s leading centres for oncology and precision medicine by providing advanced molecular diagnostics, multidisciplinary tumour boards, access to innovative therapies and clinical trials, and continued investment in advanced technologies and scientific research. 

This latest global milestone reinforces the Burjeel Cancer Institute’s commitment to providing advanced cancer treatments and scientific innovations to patients, while reflecting Abu Dhabi’s position as a leading destination for specialised care and precision oncology. 

• The clinic provides specialized care to support early diagnosis and effective treatment across workplaces 

Abu Dhabi, June 11, 2026: Lifecare Hospital - Musaffah, part of Burjeel Holdings, has launched a Seasonal Illness Clinic as part of its commitment to expanding specialized services, strengthening prevention, early detection and ensuring timely access to treatment. The clinic aims to support the health and wellbeing of workers and the wider community through integrated diagnostic and therapeutic services.  

The clinic inauguration was held in the presence of H.E. Mansoor Al Mansoori, Chairman of the Department of Health – Abu Dhabi; H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health - Abu Dhabi; Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings; and senior leaders of the Group. The clinic will provide comprehensive and affordable services, including medical assessment, treatment, preventive screening, consultations, patient education and ongoing support to all patients. 

“Musaffah is home to a large and diverse workforce that plays a vital role in the development of the UAE. Ensuring their health and safety is a shared responsibility. Through this clinic, we are bringing specialized infectious disease care, preventive screening, and health education closer to workers and the wider community. This is part of Burjeel Holdings’ commitment to accessible, responsive, and community-focused healthcare,” said Dr. Shamsheer. 

Located in one of Abu Dhabi’s key industrial areas, Lifecare Hospital, Musaffah, has long served as an important healthcare provider for Abu Dhabi’s industrial sector, supporting workers, employers, and surrounding communities with accessible medical services. Led by Dr. Rakesh Kumar Gupta, Consultant in Respiratory Medicine and Medical Director of Lifecare Hospital, Musaffah, the Seasonal Illness Clinic builds on the hospital’s extensive experience and integrated infrastructure, including dedicated isolation facilities when required.  

H.E. Dr. Faisal Al Ahbabi, Executive Director of Communicable Diseases Sector at Abu Dhabi Public Health Centre, said: “The inauguration of the Seasonal Illness Clinic reflects our ongoing efforts to provide specialized services that enhance prevention, early detection and timely intervention. This facility further safeguards the health and wellbeing of community members across the Emirate, reduces the spread of infectious diseases, and enhances the resilience of the healthcare system. This milestone aligns with Abu Dhabi’s vision to build a more proactive, prevention-led ecosystem that is human-centered and enables access to high-quality care for all.”  

The clinic focuses on the diagnosis and management of a range of common conditions, including respiratory and gastrointestinal infections, as well as skin and soft tissue infections, in addition to cases requiring specialized follow-up.  

 Leveraging Burjeel Holdings’ integrated healthcare network, the clinic will enable coordinated access to advanced diagnostic care and comprehensive clinical expertise across the Group’s healthcare network. 

Additionally, the clinic will also work closely with employers, labor accommodations and community groups to support awareness programs, screening campaigns and counseling services. By identifying infections early and ensuring appropriate treatment, the clinic aims to reduce transmission in workplaces and residential settings. 

“Our clinic is designed to extensive structured care, from screening and diagnosis to treatment, counseling, and prevention. We will also focus heavily on educating patients and empowering them to understand how to protect themselves, their families, and their colleagues.” Dr. Rakesh said. 

With the launch of the clinic, Lifecare Hospital Musaffah aims to further strengthen public health support in Abu Dhabi by combining clinical expertise, preventive healthcare, and community outreach in one dedicated service. 

The clinic provides comprehensive diagnosis and treatment of common and underdiagnosed sleep disorders through a multidisciplinary team and advanced diagnostic technologies 

Abu Dhabi, May 9, 2026: Burjeel Medical City, the flagship facility of Burjeel Holdings, has announced the launch of a specialized Sleep Clinic to address sleep disorders, one of the most common health challenges. It marks a significant step in its ongoing commitment to delivering comprehensive healthcare that enhances patients’ quality of life.  

Sleep is not a luxury, but a fundamental physiological necessity. Untreated sleep disorders are associated with serious health complications such as cardiovascular diseases, hypertension, diabetes, and impaired concentration and daily performance. This makes early diagnosis and timely intervention critically important. 

Comprehensive Care for Sleep Disorders 

The Sleep Clinic provides comprehensive services for the diagnosis and treatment of a wide range of sleep disorders through a multidisciplinary team that includes experts in pulmonology, ear, nose and throat (ENT), neurology, cardiology, and psychiatry, ensuring accurate and integrated care for every patient. It addresses a broad spectrum of sleep disorders, including sleep apnea, insomnia, narcolepsy, restless legs syndrome, and circadian rhythm disorders, conditions that often remain undiagnosed despite their significant impact on overall health and quality of life. 

The clinic offers an advanced range of services, including specialized medical consultations and sleep studies conducted both at home and in-lab (PSG), designed to accurately diagnose sleep-related issues and determine their underlying causes. It also provides advanced treatments such as Continuous Positive Airway Pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP), in addition to individualized treatment plans tailored to each patient’s condition.  

Commenting on the launch, Dr. Mujtaba Ali Khan, CEO of Burjeel Medical City, said, “The launch of the Sleep Clinic represents a valuable addition to the advanced care ecosystem at Burjeel Medical City and reflects our continuous commitment to providing integrated healthcare services centered on patients’ needs and quality of life. We believe that sleep health is a fundamental element in both prevention and treatment, and through this clinic, we aim to offer advanced diagnostic and therapeutic solutions that align with the highest international standards.” 

Dr. Humam Schakaki, Consultant in Sleep Medicine and Clinical Lead of Sleep Clinic, stated, “At the Sleep Clinic, we focus on delivering precise and comprehensive evaluations for each case, given the impact of sleep disorders on various body systems. By utilizing the latest sleep study technologies and a multidisciplinary approach, we aim to diagnose conditions early and develop individualized treatment plans that help patients restore healthy sleep patterns and significantly improve their quality of life.” 

The launch of the Sleep Clinic aligns with Burjeel Holdings’ vision to provide advanced healthcare services based on the latest technologies and global best practices, with a strong emphasis on a holistic, patient-centered approach to care.

A minimally invasive surgery at Burjeel Medical City removed part of the lung through a single 3 cm incision

Performed using the da Vinci Xi system, with all three to four robotic arms operating through the same incision

Abu Dhabi, March 23, 2026: Burjeel Medical City has successfully performed the UAE's first uniportal robotic lobectomy, a minimally invasive approach that combines robotic technology with clinical expertise, strengthening Abu Dhabi's position as a leading destination for healthcare innovation focusing on prediction, prevention, and early intervention. The milestone procedure, performed on Jean Erika, a 37-year-old patient with stage one lung cancer, redefines care for patients with early-stage cancer by opening new possibilities and improving outcomes like never before.

Recurring Dry Cough Reveals Cancer

The story of Jean Erika highlights the importance of medical evaluation when symptoms persist. She never imagined that her persistent dry cough, a symptom usually linked to common respiratory conditions, was a possible early sign of underlying cancer. "I had a recurring cough for about three weeks. Despite completing a course of antibiotics, the cough didn't subside," recalls Jean, who has been living in Abu Dhabi for the past eight years. She works as a dental nurse in a private dental center.

A CT scan with dye and a biopsy confirmed carcinoma. Her condition was discussed in a Multidisciplinary Tumor board meeting where it was decided that the best way forward was surgery. Following this, she consulted Dr. Taj Mohammed Fiyaz Chowdhry, Consultant Thoracic Surgeon, who suggested a uniportal robotic 3 cm lobectomy.

It is a procedure where a part of the lung is removed through a single 3 cm incision, with all three or four robotic arms going through the same incision.

Dr. Taj Mohammed Fiyaz Chowdhry

Consultant Thoracic Surgeon

Jean felt anxious about surgery, especially with a robot performing it. “But the doctor explained that robotic surgery would mean faster recovery and smaller wounds, which helped me feel reassured,” says Jean, who prepared herself for the surgery with the support of the medical team as well as her friends. “The entire team, including the anesthesiologist, met with me before the surgery and explained everything clearly. They made me feel comfortable and confident.”

Minimally Invasive Surgery, Faster Recovery

The surgery led by Dr. Taj lasted about four hours. He was accompanied by Dr. Nermeen Said Hassanin, Consultant Anesthesia, and Mr. Renukesh, Robotic Surgery Nurse Specialist. The team used the da Vinci Xi system, which provides precision, control, and minimally invasive access. While Dr. Chowdhry operated on the console, an experienced assistant supported the patient's side. The anesthesia team ensured the lung was isolated and the patient remained stable.

The surgery went smoothly without complications. "Normally, patients are discharged five to seven days after a traditional lobectomy. However, she was fit for discharge just two days after surgery due to minimal dissection and reduced surgical stress," says the doctor.

I realized how advanced UAE healthcare has become. As a nurse, I really appreciate how robotic surgery causes minimal scarring and less pain, and allows faster recovery, letting patients return to their normal lives sooner. At BMC, everything was efficient, and the facilities were excellent. The staff were very supportive and accommodating. They took care of all my needs and made sure I felt comfortable throughout.

Jean Erika

Patient and Dental Nurse

Jean returned to work one month after surgery.

Breakthrough in Early-Stage Cancer Care

According to Dr. Chowdhry, this approach is best suited for early stages of cancer. "For Jean, this method was chosen because she had early-stage cancer with no significant lymph node involvement and had not undergone chemotherapy or immunotherapy.

It is generally preferred not to perform this surgery on patients who have previously received chemotherapy or with bulky lymph node disease, as these factors may make it technically difficult to perform through uniportal.

Dr. Taj Mohammed Fiyaz Chowdhry

Consultant Thoracic Surgeon

BMC has been at the forefront of its robotic program since the deployment of the da Vinci system. This accomplishment reflects the strength of its multidisciplinary teams in advancing minimally invasive surgery and highlights the vision behind establishing a world‑class advanced thoracic surgery department within the facility.

•  In spite of rain, Burjeel Holdings’ frontline healthcare workers from 64 nationalities united under one banner in a powerful tribute to the UAE during the Group’s annual sports event, Burjeel Games 

• Carrying a banner measuring 85 meters and weighing over 200 kilograms, they covered a distance of 100 meters, surpassing the previous record of 58 nationalities set in Dubai in 2019 

Abu Dhabi, April 11, 2026: For weeks, they remained on the frontlines, delivering care when it mattered most. On Saturday evening, they gathered once again. However, this time, it was not in hospitals, but on a sports ground, under one banner, united for the UAE. 

In a unique tribute reflecting the nation’s spirit of solidarity, frontline healthcare workers from Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, set a Guinness World Record for the ‘Most Nationalities Carrying a Banner’, bringing together 64 nationalities in a single coordinated formation at Abu Dhabi’s Hudayriyat Island. The day witnessed rain. Despite it, people poured in by the evening and stood firm in support of the nation.  

Held during the closing ceremony of the Burjeel Games, the Group’s annual sports event in collaboration with Abu Dhabi Sports Council (ADSC), the initiative themed “Our Nation. Our Heartbeat.” transformed a sporting finale into a moment of national reflection. It was inspired by the UAE leadership’s call to raise the national flag and reinforce unity across the country. Organized within 48 hours, it became the first record-breaking event to be staged in the region after the nation reaffirmed its strength following the change in circumstances.  

A Guinness Record of Unity, Diversity, and Resilience 

At the venue, the participants carried a single banner measuring 85 meters and weighing over 200 kilograms. A total number of 153 people, including the 64 unique nationalities, walked a distance of 100 meters while holding it overhead, surpassing the previous record of 58 nationalities set in Dubai in 2019. 

Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, described the initiative as a reflection of both the UAE’s resilience and the commitment of its healthcare workforce. “We are proud to be part of a nation that brings together so many cultures under one vision. This initiative represents the resilience of the UAE and the strength of its people. In the past weeks, we have stood alongside the nation, serving communities with commitment and care. This moment reflects that same spirit, a collective expression of unity from people who call this country home,” he said. 

The attempt adhered to strict Guinness World Records guidelines, with each participant representing a unique nationality and completing the required distance in a synchronized formation. Mr. Raafat Tawfik, the official Guinness World Records adjudicator present on-site, reviewed the attempt and confirmed its success. “We are officially congratulating you on the 64 nationalities,” the adjudicator announced.  

His Excellency Aref Hamad Al Awani, Secretary-General of the Abu Dhabi Sports Council, affirmed that this achievement reflects the growing stature of Abu Dhabi as a global hub for sports and community events that blend athletics with human and national values. 

“Our partnership with Burjeel Holdings aligns with the Council’s ongoing efforts and strategic direction to support events that foster a spirit of unity and social cohesion, while highlighting the positive role of sports as a bridge connecting diverse cultures and nationalities under the banner of the UAE. Achieving a world record of this scale embodies the UAE’s message of tolerance and coexistence. It underscores that sports is not just about competition, but also a platform to celebrate diversity, teamwork, and community service,” he said. 

A Moment Deferred, Then Reimagined 

The Burjeel Games, one of the UAE’s largest healthcare sports and community events with over 2,500 participants, was originally set to conclude on February 28. However, in light of regional circumstances at the time, the final was postponed. 

As the situation evolved and the nation emerged stronger, the Burjeel community reconvened to complete the Games in a meaningful way. The finale became a platform for a larger expression, a record-setting tribute to the country that unites them. 

From Frontlines to a Moment of Unity 

For many of the participants, the moment carried deeper meaning. “Our usual days include focusing on care and being present for every patient who needs us,” said Dr. Michael George Uglow from Burjeel Medical City, a native of United Kingdom. “Today, we came together differently, as proud members of the UAE, standing under one banner.” 

Dirkie Theunissen, Group Chief Nursing Officer, who hails from South Africa, reflected on the diversity. “We work side by side with colleagues from across the world every day. Today, that diversity came alive in a powerful way. It reminded us why the UAE feels like home.” 

The initiative highlights Burjeel Holdings’ commitment to celebrating the multicultural fabric of the UAE, which is home to more than 200 nationalities, and supporting national values of unity and harmony. 

New multidisciplinary center at Burjeel Cancer Institute integrates oncology, orthopedic surgery, and advanced diagnostics under one roof.

Abu Dhabi, February 14, 2026: Burjeel Cancer Institute (BCI), one of the largest cancer care networks in the UAE, has announced the launch of its specialized Sarcoma & Bone Center at Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings in Abu Dhabi. The center has been established in collaboration with the Burjeel Orthopaedic Institute to enhance the diagnosis and treatment of rare and complex bone and soft tissue tumors.

The newly launched center brings together medical oncology, orthopedic oncology, radiation oncology, vascular surgery, radiology, rehabilitation medicine, and psychological support services within a single integrated framework. Patients benefit from coordinated care delivered by a multidisciplinary team, ensuring personalized treatment plans from diagnosis through recovery. The new center represents a major addition to highly specialized subspecialty care, reinforcing the United Arab Emirates’ position as a regional and global hub for innovation and specialized oncology services.

Sarcomas are among the rarest forms of cancer, accounting for approximately 1 percent of adult cancers and nearly 15 percent of pediatric cancers. Globally, more than 13,000 new cases are reported each year. Studies show that early diagnosis and treatment at specialized centers significantly improve survival outcomes.

The facility is equipped with advanced technologies, including PET-CT imaging, intraoperative MRI, limb-salvage microsurgery, and access to targeted therapies and immunotherapies supported by advanced genomic analysis. The center also utilizes Next-Generation Sequencing and high-resolution imaging to tailor treatment strategies based on each patient’s clinical and genetic profile.

“Our goal is to provide patients with access to specialized expertise and advanced treatment options closer to home. By bringing together oncology, surgery, diagnostics, rehabilitation, and psychosocial support in one center, we are improving the patient journey and supporting better outcomes for those affected by rare cancers,” said Professor Humaid Al Shamsi, CEO of BCI.

He added that Burjeel Cancer Institute continues to expand its network across Abu Dhabi, Dubai, Sharjah, Al Ain, and the Sultanate of Oman to ensure broader access to specialized oncology services.

Through scientific collaboration and adherence to international treatment guidelines, including those set by leading global oncology societies, the center aims to improve five-year survival rates and reduce recurrence by offering specialized, evidence-based care.

Dr. Mujtaba Ali Khan, CEO BMC, said the new center aligns with the hospital’s commitment to advancing highly specialized care.

“This launch reinforces our investment in world-class infrastructure, advanced technology, and expert clinical teams. It also supports the UAE’s vision of building a globally competitive healthcare system focused on quality, innovation, and patient-centered care,” he said.

Dr. Mohammed Muath Adi, Consultant Orthopedic Surgeon and Head of the Burjeel Orthopaedic Institute, emphasized the importance of a unified approach to treating musculoskeletal cancers.

“Managing sarcoma requires close coordination between multiple specialties. By offering comprehensive services under one roof, we are able to deliver timely diagnosis, advanced surgical techniques, and structured rehabilitation plans that enhance quality of life and long-term outcomes for our patients,” he said.

With the launch of the Sarcoma & Bone Center, BCI further strengthens its position as a regional destination for complex and subspecialized cancer care.

Specialists at Burjeel Medical City replanted the patient’s arm that was caught in a lathe machine and completely amputated at the forearm level 

Abu Dhabi: On September 29, what had been a routine workday turned into a nightmare of a lifetime for 50-year-old Tanveerullah Arif, a resident of Al Dhannah City. While working on a lathe machine, his job for the past 20 years, his left hand was unexpectedly caught in the machine, leaving the upper limb completely amputated at the forearm level. He was rushed to the nearby Burjeel Al Dhannah Hospital for initial care and subsequently transferred to Burjeel Medical City (BMC) in Abu Dhabi for advanced treatment, where a team of specialists worked in close coordination for 10 hours to replant his severed arm with record speed and meticulous precision.  

This is a successful replantation of a completely amputated mid-forearm complicated by a severe crush-avulsion injury at the level of the middle of the forearm, a highly complex surgical challenge. 

10-hour-long Emergency Replantation  

The accident happened around 4:30 pm, and the BMC team received a call from the Al Dhannah Hospital at 5:30 pm. “The emergency and civil defense teams transported the patient by road and reached BMC at 8:15 pm. He was conscious and had lost a lot of blood. Immediately, he was shifted to the operation theater, where anesthetists resuscitated him and gave him a nerve block to prepare for the remaining procedures,” says Dr. Praveen Kumar Arumugam, Specialist, Plastic and Reconstructive Surgery, BMC. 

Upon arrival, the team meticulously dissected both the amputated and severed parts to identify muscles, tendons, nerves, arteries, veins, and bones, followed by debridement, a process where the dead, damaged, or contaminated tissues are removed from the wound for better healing. 
 
It’s followed by the fixation of the forearm’s two bones, done using plates and screws. “After that, we did the arterial repair to fix blood flow, a crucial step. In his case, we repaired two arteries and four veins, followed by muscles, tendons, and nerves. During this, we put him on blood thinner to avoid clotting. Once it’s all done, we sutured the skin. After three days, during the second stage, we put a skin graft over the area where the skin was lost. Then, we gave him a cast to ensure the hand is elevated,” explains the doctor, adding that our aim is to give his hand the ability to grasp. In total, six units of blood were transfused during surgery. Anesthetists ensured there was no reperfusion injury, which could lead to heart or kidney failure. 

Besides Dr. Praveen, the plastic surgery team included Dr. Arivind Bhamidi, Specialist, Plastic Surgery, and Dr. Michael Rebeiro, Consultant Plastic Surgeon & Director of Plastic Surgery. The orthopedic team included Dr. Ahmed Hammouda, Consultant Orthopedic Surgeon, while anesthesia was handled by Dr. Mahmoud Mohamed, Specialist, Anesthesia, and Dr. Ahmed Omran, Consultant, Anesthesia and Pain Management. 

A Microsurgery Demanding Speed and Precision 

The patient, who is now able to move his hand a bit, says everything happened so quickly. The machine was running, and he just touched it. “Everything happened so quickly. The machine was running, and I just touched it and it happened. Immediately, the company’s emergency team and firefighters took me to the hospital. I was conscious then,” explains Tanveerullah, whose family in Pakistan comprises a wife and four children. According to the doctors, his young age and healthy body with no comorbidities favored the surgery. 

In scenarios like this, the golden window to preserve and reattach the severed part is six hours. Luckily, the patient reached BMC within that time frame with the severed part preserved properly, and the medical team could ensure blood flow. What made it complex was the type of injury – a combination of crush, avulsion, and amputation. “It was not a clean cut like a knife cut, but an avulsion, where the part was torn off, making it even more challenging,” says doctor Arivind Bhamidi, specialist, Plastic Surgery. 

During the patient’s transit, the team equipped themselves for the microsurgery, where they connect very small blood vessels under a microscope. It ensured there was no delay in surgical management. “It’s a coordinated effort. We had a sequence of events planned. While one team examined the severed part, the other team checked the forearm. Other sequences were done in tandem. The most challenging part was to get the blood flow quickly and ensure it reached every area of the hand. Because, despite the surgery, if the blood flow isn’t secured, it’s a lost cause,” says the doctor. 

Currently, the patient is under recovery, which includes physiotherapy for the movement of fingers, and other procedures if required after follow-up assessments. “The surgery went well, and the doctors here are taking good care of me. I’m feeling much better now. I can even move my hand a little bit again,” concludes the patient. 

What to Do in Case of a Crush or Amputation Injury? 

1. Call emergency services immediately 
Dial the local emergency number (998 in the UAE). Time is critical, especially when a limb is severed or there is heavy bleeding. 

2. Control bleeding 
Apply firm pressure to the wound using a clean cloth or bandage. If blood soaks through, do not remove the cloth. Instead, place another layer on top. 
 

3. Keep the patient calm and still 
Lay the person down and elevate the injured limb if possible to slow bleeding. Avoid giving food or drink. 

4. Preserve the severed part properly 
Gently rinse the part with clean water without scrubbing. Wrap it in sterile gauze or a clean cloth. Place it in a sealed plastic bag, then put that bag inside another bag or container filled with ice. Do not place the severed part directly on ice or in water. 
 

5. Note the time of injury 
Surgeons usually have a golden window of about six hours to attempt successful reattachment. Providing the exact time helps the medical team plan faster. 
 

6. Get to a hospital equipped for microsurgery 
Emergency responders or hospital staff can arrange transfer to the nearest emergency hospital.